MCAZ Warns The Public Against Using Benylin Paediatric Cough Syrup

MCAZ Warns The Public Against Using Benylin Paediatric Cough Syrup
The Medicines Control Authority of Zimbabwe (MCAZ) has cautioned the public against the use of Benylin Paediatric Cough Syrup, specifically batches 329303 and 329304, produced by Johnson and Johnson in South Africa.

High Levels of Toxic Contaminant Detected

The alarm was sounded by the National Agency for Food and Drug Administration (NAFDAC) of Nigeria following laboratory tests revealing alarming levels of Diethylene glycol, a hazardous contaminant known to be harmful to humans when ingested.

The toxic effects of Diethylene glycol include abdominal pain, vomiting, diarrhoea, urinary difficulties, headaches, altered mental state, and potential kidney damage, which could be fatal. Following further investigations, the South African Health Products Regulatory Authority (SAHPRA) and the manufacturer identified an additional affected batch, bringing the total to two: 329303 and 329304.
ALSO READ: Exploring The Pros And Cons Of Hybrid Cars In Zimbabwe
Benylin cough syrup
Benylin paediatric cough syrup recalled in Zimbabwe-Image Source@X
While the affected product was indeed registered for use in Zimbabwe in 2023, official import records do not corroborate the arrival of these two particular batches, raising concerns about potential illicit distribution.

Call for Vigilance and Cooperation

The MCAZ has issued a recall notice as a preemptive measure and urges the public to refrain from administering the recalled product to children.

If encountered, individuals are advised to promptly notify the authorities or healthcare providers, emphasizing the collective responsibility of safeguarding public health.

ALSO READ: Zimbabwe Introduces HIV Prevention Drug: Ministry Of Health Reveals What You Need To Know

Market Surveillance and Regulatory Measures

The Authority pledges heightened surveillance efforts through rigorous inspections and public awareness campaigns to prevent the circulation of these compromised products.

Aligned with WHO guidelines, the MCAZ reaffirms its commitment to ensuring the safety, efficacy, and quality of all medicinal products available in the market.

Encouraging Safe Procurement Practices

In light of recent events, the public is strongly advised to procure medicines exclusively from licensed sources to facilitate easier monitoring and regulation.

The MCAZ, alongside law enforcement agencies, remains steadfast in its mission to eliminate substandard and falsified healthcare products, prioritizing the well-being of the populace.

Follow Us on Google News for Immediate Updates

The post MCAZ Warns The Public Against Using Benylin Paediatric Cough Syrup appeared first on iHarare News.